Ocular devices are a growing market in both traditional pharmaceuticals and the medical device sector. Combining reliable preclinical disease models with multimodal imaging and histology can progress your pipeline forward.
Ocular devices range from common daily-use items (e.g. contact lenses) to novel orbital implants and drug-delivery devices for treatment of chronic conditions. The regulatory considerations and preclinical data required for these different products differs.
We understand how to leverage preclinical studies to support development from proof-of-concept to regulatory approval.
The rabbit has been the model of choice for most ocular preclinical studies, but other systems (e.g. porcine models) can provide other clinically relevant data in some cases.
Absorption Systems combine the most suitable model with disease states including:
- Wet AMD
- Choroidal Neovascularization (CNV)
- Corneal Wound Healing
- Keratoconjunctivitis Sicca (KCS)
- Allergic Conjunctivitis
- New Model Development
The Absorption Systems Difference
Due to our wide breadth of surgical experience and intimate knowledge of animal anatomy, Absorption Systems is able to create and induce a multitude of clinically relevant disease states in a variety of species. Working in tandem with the customer, we can create a customized disease model to test a device or use our technical expertise to access a target region within a live and dynamic animal model. From proof-of-concept and device prototyping through GLP safety and efficacy studies, we use our arsenal of institutional and scientific knowledge to help consult the client and to execute the study, always providing accurate, consistent, and reliable data.
FREQUENTLY ASKED QUESTIONS
Our state-of-the-art facilities can support regulatory approval through robust, reliable studies.
Find complete information on our ocular facilities here